Global Newswire, 27 April 2020
BOSTON, April 27, 2020 (GLOBE NEWSWIRE) — Today, research analyst Citron Research published a report calling Inovio (INO) “The COVID-19 Version of Theranos,” in which Citron slashed its target price for Inovio common stock by 93%.
Dr Left has a $1 target stock is $11 ( you know he shorted at $16-17 and covered already never waiting for his $1 target SHORT AND DISTORT for a quick profit
Comment: Company was on 60 minutes showing what they have not to pump stock but TO SAVE LIVES is under attack 24/7 they are Doctors. If we dont have people like this WE WOULD have to go see a Fucking Witch Doctor. Welcome to Fraud St. Here is Citron’s hit job on them:
PDF (12 Pages): Citron Hit Job on Inovio-Pharmaceuticals-Bad-Blood